Clinical Trials Directory

Trials / Completed

CompletedNCT06936072

Temporomandibular Joint Eminence Augmentation Using Titanium Ring Inlay: A New Surgical Technique

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
112 (actual)
Sponsor
Sinai University · Academic / Other
Sex
All
Age
25 Years – 41 Years
Healthy volunteers
Not accepted

Summary

To evaluate the efficacy of titanium ring inlay in ESS technique in Temporomandibular joint eminence augmentation

Detailed description

Background:Temporomandibular joint (TMJ) disorders affect approximately 5-12% of the population, with eminence augmentation being a challenging surgical intervention. Current techniques using autogenous grafts or alloplastic materials present limitations including donor site morbidity, resorption, and implant failure. This study evaluates a novel titanium ring inlay technique for TMJ eminence augmentation, which may offer improved stability, osseointegration, and functional outcomes. Patients and Methods: A prospective study was conducted on 100 patients (28 males, 72 females; age range: 25-41 years) with TMJ Temporomandibular joint eminence augmentation. Study was performed after ethical approval from Research Ethics Committee, Faculty of Dentistry, Sinai University OMS 01-04-024; . Titanium ring inlay procedure was performed to Temporomandibular joint eminence augmentation. Preoperative and postoperative assessments included pain levels (VAS pain), maximum mouth opening (MMO), Clicking during mouth opening, Headach presence, tinnitus and subjective patient feedback.

Conditions

Interventions

TypeNameDescription
PROCEDURETitanium Ring Inlay Eminence Augmentation* Preauricular approach with subperiosteal dissection * Dual osteotomy (transverse mid-eminence + vertical parallel to skull base) * Titanium ring inlay placement with anatomical contouring * Intraoperative functional assessment

Timeline

Start date
2024-04-28
Primary completion
2025-04-03
Completion
2025-04-03
First posted
2025-04-20
Last updated
2025-04-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06936072. Inclusion in this directory is not an endorsement.